Showing results (71-80 of 6,093) with videos related to
Sort By:
Pageof 610
Clinical Trials (London, England)|July 18, 2020
Endpoints for randomized controlled clinical trials for COVID-19 treatmentsLori E Dodd, Dean Follmann, Jing Wang, et al.The Lancet. Respiratory Medicine|May 14, 2022
Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort studyLixue Huang, Xia Li, Xiaoying Gu, et al.Immunity & Inflammation|November 24, 2025
T cell-driven sustained inflammation and immune dysregulation mimicking immunosenescence for up to three years post-COVID-19Tian Zheng, Ru Gao, Yiwei Liu, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|January 27, 2025
Efficacy and safety of single-dose suraxavir marboxil tablet in the treatment of acute uncomplicated influenza in adults: a multi-centre, randomized, double-blind, placebo-controlled phase 2 clinical trialYeming Wang, Hong Wang, Dong Liu, et al.Journal of Clinical Pharmacy and Therapeutics|November 20, 2022
Low-dose febuxostat exhibits a superior renal-protective effect and non-inferior safety profile compared to allopurinol in chronic kidney disease patients complicated with hyperuricemia: A double-centre, randomized, controlled studyNa Yang, Bin CaoCurrent Opinion in Pulmonary Medicine|December 15, 2018
Procalcitonin and other markers to guide antibiotic use in chronic obstructive pulmonary disease exacerbations in the era of antimicrobial resistanceJinxiang Wang, Bin CaoComputational Intelligence and Neuroscience|August 1, 2022
Study on Tourism Consumer Behavior and Countermeasures Based on Big DataJing Li, Bin CaoNature Medicine|January 8, 2025
Single-dose suraxavir marboxil for acute uncomplicated influenza in adults and adolescents: a multicenter, randomized, double-blind, placebo-controlled phase 3 trialYeming Wang, Hong Wang, Yu Zhang, et al.Clinics in Chest Medicine|February 5, 2017
Pandemic and Avian Influenza A Viruses in Humans: Epidemiology, Virology, Clinical Characteristics, and Treatment StrategyHui Li, Bin CaoResearch (Washington, D.C.)|April 16, 2025
Adaptive Multiobjective Evolutionary Generative Adversarial Network for Metaverse Network Intrusion DetectionDikai Xu, Bin CaoPageof 610